Contents
Article 27Delegated acts#
1.The Commission is empowered to adopt delegated acts in accordance with Article 28 for the purposes of amending, where necessary, the list of projects or programmes of Union interest, as set out in Annex II, in order to take account of the adoption or amendment of Union legal acts establishing projects or programmes that provide for the development, maintenance or acquisition of critical infrastructure, technologies, inputs or capabilities which are of particular importance for security or public order.
2.The Commission is empowered to adopt delegated acts in accordance with Article 28 for the purposes of amending, where necessary, the list of technology areas set out in Annex III, to take account of changes in the circumstances relevant to security or public order. In particular, these considerations shall include the following:
(a)the resilience of supply chains of particular importance for the security or public order;
(b)the resilience of infrastructures of particular importance for the security or public order;
(c)the results of relevant risk assessments undertaken by the Commission and Member States;
(d)the advancement of technologies of particular importance for security or public order;
(e)the risk of leakage or misuse of technologies of particular importance for security or public order;
(f)the emergence of vulnerabilities in relation to access to or other forms of processing of sensitive information, including personal data to the extent they are likely to negatively affect the security or public order;
(g)the emergence of a geopolitical situation of particular importance for security or public order; and
(h)whether the technology area has a dual-use potential.
3.The Commission is empowered to adopt delegated acts in accordance with Article 28 amending this Regulation in order to delete Annex IV and at the same time to replace the reference to that Annex in Article 19(1), point (h), with a reference to the Union List of Critical Medicinal Products and the legal acts establishing it, when that list is established by the Commission pursuant to the Regulation laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulations (EC) No 1394/2007 and (EU) No 536/2014 and repealing Regulations (EC) No 141/2000, (EC) No 726/2004 and (EC) No 1901/2006.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.